Search research articles
Contact Us
Filters
Showing results (341-350 of 361) with videos related to
Page
of 37
Sort By:
Journal of the National Cancer Institute
|
November 8, 2011
Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial
Qiu-Yan Chen, Yue-Feng Wen, Ling Guo, et al.
Plos One
|
December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Huai Liu, Bin Qi, Xiang Guo, et al.
Medical Oncology (Northwood, London, England)
|
August 20, 2013
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Huai Liu, Pei-Yu Huang, Lin-Quan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 28, 2020
Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer
Divya Thomas, Satish Sagar, Xiang Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma
Pei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Nature Communications
|
July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
Nan Niu, Jinqi Xue, Guanglei Chen, et al.
Nature Communications
|
November 17, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
Nan Niu, Fang Qiu, Qianshi Xu, et al.
Cancer Communications (London, England)
|
September 27, 2018
Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies
Chaofeng Li, Bingzhong Jing, Liangru Ke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
Xiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Su-Mei Cao, Qi Yang, Ling Guo, et al.
Page
of 37
Search research articles
Search
Showing results (341-350 of 361) with videos related to
Sort By:
Page
of 37
Journal of the National Cancer Institute
|
November 8, 2011
Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial
Qiu-Yan Chen, Yue-Feng Wen, Ling Guo, et al.
Plos One
|
December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Huai Liu, Bin Qi, Xiang Guo, et al.
Medical Oncology (Northwood, London, England)
|
August 20, 2013
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy
Huai Liu, Pei-Yu Huang, Lin-Quan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
December 28, 2020
Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer
Divya Thomas, Satish Sagar, Xiang Liu, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma
Pei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Nature Communications
|
July 2, 2025
Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial
Nan Niu, Jinqi Xue, Guanglei Chen, et al.
Nature Communications
|
November 17, 2022
A multicentre single arm phase 2 trial of neoadjuvant pyrotinib and letrozole plus dalpiciclib for triple-positive breast cancer
Nan Niu, Fang Qiu, Qianshi Xu, et al.
Cancer Communications (London, England)
|
September 27, 2018
Development and validation of an endoscopic images-based deep learning model for detection with nasopharyngeal malignancies
Chaofeng Li, Bingzhong Jing, Liangru Ke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2022
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial
Xiao-Yun Li, Dong-Hua Luo, Ling Guo, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2017
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial
Su-Mei Cao, Qi Yang, Ling Guo, et al.
Page
of 37